Literature DB >> 32472110

Aspirin as a painkiller in patients with a high cardiovascular risk profile.

Rainer Spiegel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32472110     DOI： 10.1038/s41569-020-0398-4

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  4 in total

1.  Reply to 'Aspirin as a painkiller in patients with a high cardiovascular risk profile'.

Authors:  Anne-Marie Schjerning; Patricia McGettigan; Gunnar H Gislason
Journal:  Nat Rev Cardiol       Date:  2020-09       Impact factor: 32.419

Review 2.  Perioperative Opioid-sparing Strategies: Utility of Conventional NSAIDs in Adults.

Authors:  Luc Martinez; Evan Ekman; Nardine Nakhla
Journal:  Clin Ther       Date:  2019-11-14       Impact factor: 3.393

Review 3.  Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data.

Authors:  Michèle Bally; Nandini Dendukuri; Benjamin Rich; Lyne Nadeau; Arja Helin-Salmivaara; Edeltraut Garbe; James M Brophy
Journal:  BMJ       Date:  2017-05-09

4.  Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project.

Authors:  Gwen M C Masclee; Huub Straatman; Andrea Arfè; Jordi Castellsague; Edeltraut Garbe; Ron Herings; Bianca Kollhorst; Silvia Lucchi; Susana Perez-Gutthann; Silvana Romio; René Schade; Tania Schink; Martijn J Schuemie; Lorenza Scotti; Cristina Varas-Lorenzo; Vera E Valkhoff; Marco Villa; Miriam C J M Sturkenboom
Journal:  PLoS One       Date:  2018-11-01       Impact factor: 3.240
  4 in total
  2 in total

1.  Reply to 'Aspirin as a painkiller in patients with a high cardiovascular risk profile'.

Authors:  Anne-Marie Schjerning; Patricia McGettigan; Gunnar H Gislason
Journal:  Nat Rev Cardiol       Date:  2020-09       Impact factor: 32.419

Review 2.  Non-Steroidal Anti-Inflammatory Drugs in Colorectal Cancer Chemoprevention.

Authors:  Jadwiga Maniewska; Dagmara Jeżewska
Journal:  Cancers (Basel)       Date:  2021-02-03       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.